Skip to main content

Additional effects of FDG-PET to thin-section CT for the differential diagnosis of lung nodules: a Japanese multicenter clinical study

Abstract

Objective

This study was a controlled multicenter clinical study on patients with peripheral lung nodules to verify the improvement in the diagnostic ability of FDG-PET when used in combination with thin-section CT (TS-CT).

Methods

Patients with peripheral lung nodules (long maximal diameter: 10–30 mm) detected using CT were examined using TS-CT and FDG-PET for the differential diagnosis of benign or malignant lesions. The primary endpoint was the specificity of the results using a combination of TS-CT and FDG-PET, compared with the results for TS-CT alone. Images were interpreted by investigators at each institution. Blind readings were also performed by an independent image interpretation committee. The gold standard was a pathological diagnosis determined using a surgical or biopsy specimen obtained after PET; and the patients in whom a pathological diagnosis could not be obtained were diagnosed based on a follow-up TS-CT performed more than 6 months later. Adverse reactions to FDG were also evaluated.

Results

The blind reading results for 82 lesions in 81 subjects eligible for analysis among the 90 subjects included in the study showed a specificity of 91.2% (31/34) (95% CI: 76.3–98.1) for TS-CT + PET, compared with a specificity of 67.6% (23/34) (95% CI: 49.5–82.6) for TS-CT alone. The specificity was significantly improved by the addition of the PET findings (p < 0.05). The sensitivity improved from 89.6% (43/48) for TS-CT to 91.7% (44/48) for TS-CT + PET; the addition of PET increased the level of confidence in the diagnosis, but the difference was not significant. The results reported by the institutional investigators were not significantly different. No serious adverse reactions occurred, although two of the 90 subjects exhibited mild adverse reactions.

Conclusions

The addition of FDG-PET to TS-CT for the differential diagnosis of benign or malignant peripheral lung nodules resulted in a significant improvement in specificity. Although a definitive diagnosis of lung nodules requires a histopathological or cytological examination, when combined with TS-CT, FDG-PET can provide additional diagnostic information and improve the specificity.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3

References

  1. The Japan Lung Cancer Society. Lung cancer clinical practice guidelines by the EBM approach. Kanehara Shuppan, Japan; 2010.

  2. Gould MK, Maclean CC, Kuschner WG, Rydzak CE, Owens DK. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA. 2001;285:914–24.

    PubMed  Article  CAS  Google Scholar 

  3. Demura Y, Tsuchida T, Ishizaki T, Mizuno S, Totani Y, Ameshima S, et al. 18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax. J Nucl Med. 2003;44:540–8.

    PubMed  CAS  Google Scholar 

  4. Imdahl A, Jenkner S, Brink I, Nitzsche E, Stoelben E, Moser E, et al. Validation of FDG positron emission tomography for differentiation of unknown pulmonary lesions. Eur J Cardiothorac Surg. 2001;20:324–9.

    PubMed  Article  CAS  Google Scholar 

  5. Präuer HW, Weber WA, Römer W, Treumann T, Ziegler SI, Schwaiger M. Controlled prospective study of positron emission tomography using the glucose analogue [18F]Fluorodeoxyglucose in the evaluation of pulmonary nodules. Br J Surg. 1998;85:1506–11.

    PubMed  Article  Google Scholar 

  6. Lowe VJ, Fletcher JW, Gobar L, Lawson M, Kirchner P, Valk P, et al. Prospective investigation of positron emission tomography in lung nodules. J Clin Oncol. 1998;16:1075–84.

    PubMed  CAS  Google Scholar 

  7. Gupta NC, Maloof J, Gunel E. Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET. J Nucl Med. 1996;37:943–8.

    PubMed  CAS  Google Scholar 

  8. Sazon DA, Santiago SM, Soo Hoo GW, Khonsary A, Brown C, Mandelkern M, et al. Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer. Am J Respir Crit Care Med. 1996;153:417–21.

    PubMed  CAS  Google Scholar 

  9. Christensen JA, Nathan MA, Mullan BP, Hartman TE, Swensen SJ, Lowe VJ. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT. AJR Am J Roentgenol. 2006;187:1361–7.

    PubMed  Article  Google Scholar 

  10. Schillaci O, Travascio L, Bolacchi F, Calabria F, Bruni C, Cicciò C, et al. Accuracy of early and delayed FDG PET–CT and of contrast-enhanced CT in the evaluation of lung nodules: a preliminary study on 30 patients. Radiol Med. 2009;114:890–906.

    PubMed  Article  CAS  Google Scholar 

  11. FDA guidance for industry developing medical imaging drugs and biological products. Part 3: Design, analysis, and interpretation of clinical studies; 2004.

  12. Guidelines on clinical evaluation of radioactive diagnostics. Japanese Society of Nuclear Medicine, Japan; 2005.

Download references

Acknowledgments

We thank the patients, clinical research coordinators, radiologists and subinvestigators for their participation in this study. Also we thank Ms. Akiko Shibuya, for her contribution to prepare manuscript. This study was sponsored by Nihon Medi-Physics co., Ltd, Tokyo, Japan.

Conflict of interest

Dr. Shiomi currently has the conflict of interest with the company while other authors do not.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Kazuo Kubota.

Appendix:

Appendix:

Institutions of the Study: National Cancer Center Hospital East, Yokohama City University Hospital, Kyoto University Hospital, Osaka City University Hospital.

Members of the Study Organization were as follows:

Independent Image Interpretation Committee: E. Tsukamoto, T. Nambu; Hokkaido University Hospital. M. Sasaki, S. Sakai; Kyushu University Hospital.

Independent Entry Criteria Judging Committee: H. Itoh; Fukui Medical University Hospital.

Protocol Exploratory Committee: S. Kudo; Osaka City University Hospital. F. Tanaka; Kyoto University Hospital. K.Murakami; National Cancer Center Hospital East.

Investigators: H. Ikeda, K. Murakami; National Cancer Center Hospital East., J. Konishi, T. Saga; Kyoto University Hospital., H. Ochi, S. Shiomi; Osaka City University Hospital., T. Inoue; Yokohama City University Hospital.

Coordinating Investigator: K.Kubota; National Center for Global Health and Medicine.

Medical consultants of the sponsor: K. Torizuka; Professor Emeritus, Kyoto University, Y.Takagi; Department of Clinical Pathology, and Office of Medical Education, Showa University.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kubota, K., Murakami, K., Inoue, T. et al. Additional effects of FDG-PET to thin-section CT for the differential diagnosis of lung nodules: a Japanese multicenter clinical study. Ann Nucl Med 25, 787–795 (2011). https://doi.org/10.1007/s12149-011-0528-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12149-011-0528-5

Keywords

  • Solitary pulmonary nodule
  • FDG-PET
  • CT
  • Multicenter study